1. Effects of pregnancy and contraception on lamotrigine disposition: New insights through analysis of lamotrigine metabolites 
Inger Öhman, Gerhard Luef, Torbjörn Tomson 
Seizure - European Journal of Epilepsy 
Volume 17, Issue 2, Pages (March 2008)
DOI: /j.seizure
Copyright © 2007 British Epilepsy Association Terms and Conditions

2. Figure 1
Dose/lamotrigine plasma concentration ratios in 20 non-users of oral contraceptives (controls), 12 users of intrauterine contraception devices containing progestin (CIUD), and 31 users of combined oral contraceptives (COC).
Seizure - European Journal of Epilepsy  , DOI: ( /j.seizure )
Copyright © 2007 British Epilepsy Association Terms and Conditions

3. Figure 2
Lamotrigine 2-N-glucuronide/lamotrigine plasma concentration ratios in 20 non users of oral contraceptives (controls), 12 users of intrauterine contraception devices containing progestin (CIUD), and 31 users of combined oral contraceptives (COC).
Seizure - European Journal of Epilepsy  , DOI: ( /j.seizure )
Copyright © 2007 British Epilepsy Association Terms and Conditions

4. Figure 3
Lamotrigine 2-N-glucuronide/lamotrigine plasma concentration ratio at different stages of pregnancy and up to three months postpartum in eight women treated with lamotrigine during pregnancy.
Seizure - European Journal of Epilepsy  , DOI: ( /j.seizure )
Copyright © 2007 British Epilepsy Association Terms and Conditions

5. Figure 4
Lamotrigine 2-N-glucuronide/lamotrigine urine concentration ratio at different stages of pregnancy and up to three months postpartum in eight women treated with lamotrigine during pregnancy.
Seizure - European Journal of Epilepsy  , DOI: ( /j.seizure )
Copyright © 2007 British Epilepsy Association Terms and Conditions